Landscapes / Companies
Dermavon Holdings Limited not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
4 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2/3 | 31 Jan 2027Phase 2 trial completes | |||
| Next date | 31 Jan 2027 · Phase 2 trial completes | ||||
| Also tested for | Moderate to Severe Plaque Psoriasis, Moderate to Severe Atopic Dermatitis | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2027Phase 1 trial completes | |||
| Next date | Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021